JSA advises Biocon Biologics on sale of its Indian branded formulations business to Eris Lifesciences

Biocon Biologics Limited has sold its Indian branded formulations business to Eris Lifesciences Limited for an aggregate consideration of ₹1,242 Crore.

Related Keywords

Probir Roy Chowdhury ,Biocon ,Lead Partner ,Yajas Setlur ,Soumya Bhargava ,Senior Associate ,Moushami Nayak ,Nikhil George ,Mjsa ,Biocon Biologics ,Eris Lifesciences ,Sale Of Formulation ,Supply Agreement ,Indian Law Firms ,Law Firm News ,News ,Deals ,